Skip to content

Andy S. Goberdhan, MD

NPI 1386823425ActiveIndividual· Internal Medicine, Hematology & Oncology· Philadelphia, PA

Internal Medicine, Hematology & Oncology (MD) in Philadelphia, Pennsylvania, trained at Drexel University College of Medicine (class of 2025). Part D covered 48 prescriptions written in 2024, 58% of them generic. Merck Sharp & Dohme LLC reported $20.34 in payments in 2025, mostly food and beverage.

Overview

NPI1386823425
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedOct 25, 2007
Last updated in NPPESApr 29, 2026
Certified by providerApr 29, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Hematology/Oncology (NY); Practitioner - Hematology/Oncology (PA); Practitioner - Hospitalist (SC)

Part D prescriptions in 2024

Prescriptions (claims)48 · 67 30-day fills
Patients21
Total drug cost$51,143
Generic share58% of claims

Medicare sources and data years

Education and affiliations

Medical schoolDrexel University College of Medicine
Graduation year2025
Medicare specialtyHospitalist

Medical group

Hospital affiliation

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$20.34 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Merck Sharp & Dohme LLC$20.341

What the 2025 payments were for

  • Food and Beverage$20.34 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other hematologist-oncologists in Philadelphia

All 210 hematologist-oncologists in Philadelphia · All hematologist-oncologists in Pennsylvania